**Abstract**

PKD (paroxysmal kinesigenic dyskinesia) is an autosomal dominant disorder characterized by brief but frequent attacks triggered by involuntary sudden movements, and is often misdiagnosed as common epilepsy. PRRT2 (proline-rich transmembrane protein 2) was identified as a causative gene of familial PKD in 2011 (1, 2), and almost all PKD-linked PRRT2 gene mutations bring a lack of two C-terminal transmembrane regions of PRRT2 proteins, resulting in their subcellular mislocalization in neurons. Therefore, a cause of PKD is supposed to be loss of functions of PRRT2, although its physiological functions are poorly understood. However, PRRT2 may be implicated in neuronal hyperexcitability, as it was reported that PRRT2 interacted with GluR1, a subunit of AMPA receptor (3). In this study we investigated a neuronal activity-dependent processing of PRRT2 during neuronal excitation. When we treated mouse cortical primary neurons with glutamate, we found that PRRT2 was processed immediately after the neuronal excitation and a 15 kDa fragment was generated. Since the fragment was detected in membrane fraction, not in cytosolic fraction, the fragment includes the C-terminal transmembrane regions of PRRT2. To identify proteases responsible for this processing, we treated neurons with various protease inhibitors together with glutamate. We found that generation of the fragment was inhibited by a serine protease inhibitor leupeptin. Because generation of the 15 kDa C-terminal fragment (15K-CTF) is induced by glutamate, it may be involved in regulation of activity-dependent neuronal excitability. Given that many mutants of PRRT2 linked to PKD lack the C-terminal transmembrane regions of PRRT2, the processing is required for physiological functions of neurons, the 15K-CTF may play a critical role in limited functions of PRRT2. We are currently analyzing exact pathophysiological functions of the 15K-CTF as well as full-length PRRT2. (279 words →281)
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